TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
WGS

GeneDx Holdings Corp.

Healthcare · Diagnostics & Research

68.50$ -4.2% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Income Statement

GeneDx Holdings Corp. (WGS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 114 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement WGS
Line item Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
39 64 64 47 43 58 54 36 83 61 43 49 53 57 62 71 77 96 87 103 117 121 102 114 454
37 64 69 48 51 49 48 66 70 78 28 30 28 27 25 28 29 29 29 32 32 42 34 36 145
2.1 0.4 -4.3 -1.2 -8.3 9.2 5.6 -30 14 -16 15 19 25 31 37 43 48 66 58 71 85 79 68 78 310
19 31 53 12 18 22 21 27 13 24 15 17 14 12 12 11 12 12 13 15 20 24 20 20 83
24 61 102 13 33 58 47 71 55 41 44 37 26 27 23 26 26 27 32 27 44 47 75 73 238
58 125 192 44 80 125 95 133 104 309 76 70 68 56 51 54 56 57 63 62 88 93 94 96 371
-56 -125 -197 -45 -88 -116 -89 -163 -91 -325 -60 -52 -43 -26 -14 -11 -7.8 8.8 -4.6 9.0 -3.3 -14 -26 -17 -61
0.6 0.6 0.7 0.7 0.7 0.7 0.8 0.8 0.8 0.8 0.8 0.6 – 1.0 0.6 0.9 0.8 0.7 0.6 0.8 0.6 0.5 0.7 1.2 3.0
-57 -126 -192 -46 33 -40 -77 -135 -78 -309 -61 -47 -42 -26 -20 -29 -8.4 5.4 -6.1 11 -7.4 -18 -62 -18 -106
0.6 0.6 6.3 -5.6 0.2 0.7 -12 -49 -0.1 0.1 -0.1 -0.2 -0.2 -0.4 -0.1 -0.2 0.0 0.0 0.4 -0.2 0.2 -0.6 0.9 0.5 1.1
-57 -126 -192 -46 33 -40 -77 -86 -78 -309 -61 -47 -42 -26 -20 -29 -8.3 5.4 -6.5 11 -7.6 -18 -63 -18 -106
-56 -121 -186 -40 39 -34 -70 -125 -66 -274 -52 -36 -26 -19 -14 -23 -1.6 12 0.2 18 -0.4 -11 -55 -10 -76

LTM = last twelve months (sum of the four most recent quarters).

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?